当前位置：首页 > 文献互助 > 互助详情

Lipid-Lowering Efficacy and Safety of Oral Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-Analysis复制

定风波 1小时前 3 10 求助中 帖子自动结束时间: 2025-12-09 14:17:00

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1007/s12325-025-03418-x复制

文献链接: https://link.springer.com/10.1007/s12325-025-03418-x复制

其他信息:

出版社: Springer Science and Business Media LLC
作者: Walter Masson; Martín Lobo; Gustavo Giunta; Leandro Barbagelata; Juan P. Nogueira
全文下载地址: https://link.springer.com/content/pdf/10.1007/s12325-025-03418-x.pdf

上一篇：Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study

下一篇：WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials

互助时间线

2025-12-04 14:17:00 [发起求助]

最新发布的求助

Novel antennae for the sensitization of near infrared luminescent lanthanide cations 14分钟前
Sputtered Indium‐Zinc Oxide for Buffer Layer Free Semitransparent Perovskite Photovoltaic Devices in Perovskite/Silicon 4T‐Tandem Solar Cells 18分钟前
Up-conversion phosphor LaCaGaO4: Er3+/Yb3+ for the optical temperature sensing and anti-counterfeiting 22分钟前
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn’s-like inflammatory bowel disease 28分钟前
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances 47分钟前
WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials 47分钟前
Lipid-Lowering Efficacy and Safety of Oral Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-Analysis 1小时前
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study 2小时前
Explaining Automated Vehicle Behavior at an Appropriate Abstraction Level and Timescale to Maintain Common Ground 3小时前
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial 3小时前
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials 4小时前
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com